Microbiota Dynamics: A Key Factor in Hirudotherapy-Related Infections?
Karasartova D, Arslan-Akveran G, Sensoz S, Mumcuoglu KY, Taylan-Ozkan A (2025) · Microorganisms · n=0
Study Profile
- Design
- experimental microbiology study using 16S rRNA V3-V4 region amplicon sequencing on the Illumina NovaSeq platform to characterize the gastrointestinal microbiota of three medicinal leech groups: long-fasting farmed leeches, recently fed farmed leeches (bovine blood), and wild specimens fed amphibian blood (Hitit University Faculty of Medicine, Turkiye; Hadassah Medical School, Hebrew University, Jerusalem, Israel; International Cyprus University)
- Sample size (n)
- 0
- Intervention
- Comparative 16S rRNA metasequencing of leech mouth, pharynx, crop, and intestinal microbiota across the three leech groups; identification of environmental versus symbiotic/probiotic bacterial families and opportunistic pathogens with implications for hirudotherapy infection risk
- Comparator
- Within-study comparison of microbiota composition across the three leech groups; no clinical patient outcomes as comparator
- Primary endpoint
- Identification of bacterial families, symbiotic/probiotic populations, and opportunistic pathogens in the medicinal leech digestive tract that could pose hirudotherapy-related infection risk
- Primary result
- Significant microbiota differences were found across leech groups and across digestive system regions; environmental bacteria were present in all groups to varying degrees; first-time identification of certain opportunistic pathogens in the studied leech species; authors concluded that extensive screening for opportunistic pathogens should be performed on leeches intended for medical use and that long-fasting leeches from specialized farms are recommended for hirudotherapy
- Follow-up duration
- not applicable - cross-sectional microbiology characterization
- PMID
- 40284753
Key Findings
- Comprehensive 16S rRNA metasequencing of medicinal leech microbiota across fasting state, blood meal source, and farming origin
- First-time identification of certain opportunistic pathogens in the studied leech species — direct relevance to hirudotherapy safety
- Demonstrates that fasting state and blood meal source significantly influence leech microbiota composition
- Provides scientific basis for the institutional recommendation that hirudotherapy use only specialized-farm long-fasting leeches
- Reinforces the need for routine pathogen screening of leeches intended for medical use
Limitations
- Cross-sectional microbiology characterization - does not provide patient-level outcome data
- 16S rRNA sequencing identifies bacterial families but not strain-level pathogenicity
- Limited sample size per leech group - inference about broader populations preliminary
- No comparison to leeches from different geographic regions or farming standards
- Pathogenicity of identified opportunistic organisms requires culture-based confirmation
Clinical Implications
Karasartova 2025 provides modern microbiological evidence supporting the institutional standard that medicinal leech therapy use only specialized-farm long-fasting leeches with documented microbiology screening. For US clinicians and institutions providing K040187-cleared leech therapy, the trial reinforces the importance of vendor selection (FDA-registered specialized farms), batch microbiology surveillance, and routine pathogen screening as part of an antibiotic-stewardship program. The trial complements Beka 2018 (ciprofloxacin resistance), Wilmer 2013 (Vancouver surveillance), and Reese 2015 (Greifswald infection series) in framing the contemporary leech-microbiology safety landscape.
Related Trials
Medicinal leech therapy in venous congestion of microsurgical flaps: a randomized comparison with heparin pinprick scarification
Merlino G, Carbone S, Servillo G, Marletta DA (2020)
Adjunctive medicinal leech therapy for venous congestion in free flaps: a German multicenter randomized trial
Lehnhardt M, Daigeler A, Behr B, Schmidt SV, Wallner C (2021)
Medicinal leeches and the microsurgeon: a four-year study, clinical series and risk benefit review
Whitaker IS, Josty IC, Hawkins S, Azzopardi E, Naderi N, Graf J, Damaris L, Lineaweaver WC, Kon M (2011)
Medicinal leeches for surgically uncorrectable venous congestion after free flap breast reconstruction
Pannucci CJ, Nelson JA, Chung CU, Fischer JP, Kanchwala SK, Kovach SJ, Serletti JM, Wu LC (2014)